U.S., March 19 -- ClinicalTrials.gov registry received information related to the study (NCT07480486) titled 'Pharmacogenetic-Guided Antidepressant Treatment in Depression' on March 14.
Brief Summary: The purpose of this clinical trial is to evaluate whether using pharmacogenetic testing to guide antidepressant treatment can improve outcomes in adults with major depressive disorder in Morocco. Depression is a common mental health condition, and finding the most effective antidepressant for a patient can take time. Some individuals do not respond well to the first medication prescribed or may experience side effects.
Pharmacogenetic testing examines genetic variations that can influence how a person processes certain medications. Informati...